Abiomed
ABMD
#1109
Rank
โ‚น1.451 T
Marketcap
โ‚น32,189
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): โ‚น83.43 Billion

According to Abiomed's latest financial reports the company's current revenue (TTM ) is โ‚น90.73 Billion. In 2021 the company made a revenue of โ‚น74.66 Billion an increase over the revenue in the year 2020 that were of โ‚น59.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚น83.43 B11.75%
2021 โ‚น74.66 B25.59%
2020 โ‚น59.45 B-0.9%
2019 โ‚น59.99 B16.45%
2018 โ‚น51.51 B48.32%
2017 โ‚น34.73 B23.29%
2016 โ‚น28.17 B39.85%
2015 โ‚น20.14 B49.1%
2014 โ‚น13.51 B23.64%
2013 โ‚น10.92 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น255.62 B 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.286 T 1,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น37.81 B-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA